Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-26-028902
Filing Date
2026-06-16
Accepted
2026-06-16 16:36:28
Documents
62
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A form10-ka.htm   iXBRL 10-K/A 830068
2 EX-31.1 ex31-1.htm EX-31.1 7636
3 EX-32.1 ex32-1.htm EX-32.1 8635
  Complete submission text file 0001493152-26-028902.txt   4476071

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE pulm-20251231.xsd EX-101.SCH 35192
5 XBRL CALCULATION FILE pulm-20251231_cal.xml EX-101.CAL 56310
6 XBRL DEFINITION FILE pulm-20251231_def.xml EX-101.DEF 121910
7 XBRL LABEL FILE pulm-20251231_lab.xml EX-101.LAB 356431
8 XBRL PRESENTATION FILE pulm-20251231_pre.xml EX-101.PRE 275139
65 EXTRACTED XBRL INSTANCE DOCUMENT form10-ka_htm.xml XML 544005
Mailing Address 945 CONCORD STREET SUITE 1217 FRAMINGHAM MA 01701
Business Address 945 CONCORD STREET SUITE 1217 FRAMINGHAM MA 01701 (888) 355-4440
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

EIN.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36199 | Film No.: 261095169
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)